Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Activation of group-I metabotropic glutamate receptors, mGlu1 and mGlu5, triggers a variety of signalling pathways in neurons and glial cells, which are differently implicated in synaptic plasticity. The earliest and much of key studies discovered abnormal mGlu5 receptor function in Fragile X syndrome (FXS) mouse models which then motivated more recent work that finds mGlu5 receptor dysfunction in related disorders such as intellectual disability (ID), obsessive-compulsive disorder (OCD) and autism. Therefore, mGlu1/5 receptor dysfunction may represent a common aetiology of these complex diseases. Furthermore, many studies have focused on dysregulation of mGlu5 signalling to synaptic protein synthesis. However, emerging evidence finds abnormal mGlu5 receptor interactions with its scaffolding proteins in FXS which results in mGlu5 receptor dysfunction and phenotypes independent of signalling to protein synthesis. Finally, both an increased and reduced mGlu5 functioning seem to be associated with ID and autism spectrum disorders, with important consequences for potential treatment of these developmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 12×
“Thus, disruption of mGlu5-Homer interaction is not involved in the abnormal translational control of FMRP target mRNAs.”
BackgroundInfluentialAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 1×
“Local translation of synaptic mRNAs FXS is the most common inherited form of ID and a leading genetic cause of autism (Abrahams and Geschwind, 2008; Kelleher and Bear, 2008).”
BackgroundBoosting slow oscillations during sleep potentiates memory
Marshall, L., Helgadóttir, H., Mölle, M., & Born, J. (2006) · Nature · doi:10.1038/nature05278 · Cited by 1,792
Coordinated memory replay in the visual cortex and hippocampus during sleep
Ji, D., & Wilson, M. A. (2007) · Nature Neuroscience · doi:10.1038/nn1825 · Cited by 1,669 · cited 1×
“When UP states occur spontaneously and repeatedly, they underlie the neocortical “slow oscillation” (<1 Hz) during slow wave sleep and may be involved in long-term memory consolidation (Crunelli and Hughes, 2010; Ji and Wilson, 2007; Marshall and Born, 2007; Marshall et al., 2006).”
BackgroundEndogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · cited 1×
“CB1 receptors are abundantly expressed on pre-synaptic terminals of GABAergic/Cholecystokinin positive interneurons (Katona et al., 1999; Wilson and Nicoll, 2001).”
BackgroundDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 2×
“Interestingly, defects in mGlu5 receptor-dependent ERK1/2 phosphorylation were not rescued by overexpression of two Shank3 carrying mutations that have been found in patients with autism (Durand et al., 2007), suggesting that alteration of mGlu5 receptor signalling might be a common mechanism in Phelan Mc Dermid disea…”
BackgroundShank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570 · cited 2×
“However, in Shank 1 and Shank 3 mutant mice a reduction of Homer1 proteins might implicate an alteration of mGlu5-mediated signalling in these mutant mice (Hung et al., 2008; Peça et al., 2011; Wang et al., 2011), whereas only NMDA receptor mediated signalling appear to be impaired in Shank 2 mutant mice (Won et al.”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 4×
“…and non syndromic autism The first studies aimed at investigating the expression of mGlu5 receptor in the brain of Fragile X mouse models revealed no changes in levels of protein expression in hippocampal homogenates (Huber et al., 2002) and forebrain synaptosomes (Giuffrida et al., 2005).”
BackgroundResultSelf-citationThe TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 1×
“These two proteins behave as GAPs (GTPase-activating proteins) of the small GTP-binding protein, Rheb (Ras homologue enriched in brain), thereby restraining the activation of mTORC1 (mammalian target of rapamycin complex 1) (Huang and Manning, 2008).”
BackgroundKatona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 1×
“CB1 receptors are abundantly expressed on pre-synaptic terminals of GABAergic/Cholecystokinin positive interneurons (Katona et al., 1999; Wilson and Nicoll, 2001).”
BackgroundShigemoto, R., Kinoshita, A., Wada, E., Nomura, S., Ohishi, H., Takada, M., Flor, P. J., Neki, A., Abe, T., Nakanishi, S., et al. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07503.1997 · Cited by 1,116
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Baude, A., Nusser, Z., Roberts, J. D. B., Mulvihill, E., Jeffrey Mcllhinney, R. A., & Somogyi, P. (1993) · Neuron · doi:10.1016/0896-6273(93)90086-7 · Cited by 927 · cited 1×
“In dendritic spines, mGlu1 and mGlu5 receptors are typically localized in the perisynaptic region, and can therefore be recruited by the high levels of glutamate that are released during sustained synaptic transmission (Baude et al., 1993; Nusser et al., 1994; Vidnyanszky et al., 1996).”
BackgroundTu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · cited 1×
“…(TRPC), the phosphatidylinositol-3-kinase enhancer (PIKE), dynamin III, drebrin, oligophrenin-1 and diacylglycerol lipase-alpha (DGLα) (Feng et al., 2002; Gray et al., 2003; Jung et al., 2007; Kammermeier et al., 2000; Kim et al., 2006; Rong et al., 2003; Tu et al., 1998, 1999; Yuan et al., 2003).”
BackgroundCortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J.-D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., et al. (2007) · Nature · doi:10.1038/nature06104 · Cited by 852 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript positive response to fluoxetine (Welch et al., 2007).”
BackgroundAutism‐like behavioral phenotypes in BTBR T+tf/J mice
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812 · cited 1×
“The BTBR mouse is an inbred mouse strain that shows robust behaviours analogous to autism in humans, such as reduced social interaction, repetitive behaviours and altered vocalizations (McFarlane et al., 2008).”
BackgroundAutistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., et al. (2012) · Nature · doi:10.1038/nature11208 · Cited by 695 · cited 2×
“While in disorders associated to SHANK3 mutation mGlu5 PAMs might work by restoring the function of mGlu5 receptors, they may also be beneficial in other forms of ASD, such as those caused by mutations of SHANK2 where they promote the mGlu5-mediated enhancement of NMDA function (Won et al., 2012).”
BackgroundThe contribution of sleep to hippocampus-dependent memory consolidation
Marshall, L., & Born, J. (2007) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.09.001 · Cited by 667
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644 · cited 1×
“FXS was first linked to group-I mGlu receptors when FMRP was shown to be rapidly synthesized in synaptoneurosomes in response to group-I mGlu agonists (Weiler et al., 1997).”
BackgroundBourgeron, T. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.06.003 · Cited by 637 · cited 2×
“Furthermore, mutations of SHANK3 are the most frequent among the rare variants found in autism (for review see Betancur and Buxbaum, 2013; Bourgeron, 2009) and have also been detected in non syndromic form of ID (Gong et al.”
BackgroundLu, Y.-M., Jia, Z., Janus, C., Henderson, J. T., Gerlai, R., Wojtowicz, J. M., & Roder, J. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05196.1997 · Cited by 634
Lüscher, C., & Huber, K. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.016 · Cited by 627 · cited 1×
“While a detailed discussion of mGlu-LTD mechanisms is beyond the scope of this review, there have been several excellent reviews focused on mGluLTD (Asrar and Jia, 2013; Gladding et al., 2009; Lüscher and Huber, 2010).”
BackgroundSelf-citationThe Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.589 · Cited by 563 · cited 1×
“More recently, SHANK1 and SHANK2 have been also implicated in autism (Berkel et al., 2010; Sato et al., 2012).”
BackgroundAbnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560 · cited 1×
“No major brain malformation have been found in FXS; however, a higher density of dendritic spines, which appear long and immature, have been reported in both FXS patients and in the Fmr1 KO mouse model of the disease (Irwin et al., 2001; Nimchinsky et al., 2001).”
Dysregulation of mTOR signaling in fragile X syndrome
Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3
Wang, X., McCoy, P. A., Rodriguiz, R. M., Pan, Y., Je, H. S., Roberts, A. C., Kim, C. J., Berrios, J., Colvin, J. S., Bousquet-Moore, D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr212 · Cited by 537
Hou, L., & Klann, E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0995-04.2004 · Cited by 527
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · cited 1×
“Pharmacological antagonism of mGlu5 completely blocks audiogenic seizures in Fmr1 KO mice (Yan et al., 2005).”
BackgroundKim, E., Naisbitt, S., Hsueh, Y.-P., Rao, A., Rothschild, A., Craig, A. M., & Sheng, M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.3.669 · Cited by 516 · cited 1×
“SAP90/PSD-95 associated proteins (SAPAPs, also referred to as GKAPs) are scaffolding proteins linking NMDA/PSD95 complex to mGlu/Homer (Kim et al., 1997; Takeuchi et al., 1997; Tu et al., 1999).”
BackgroundPark, S., Park, J. M., Kim, S., Kim, J.-A., Shepherd, J. D., Smith-Hicks, C. L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A. G., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.023 · Cited by 516 · cited 5×
“This step is believed to favour the rapid synthesis of specific proteins, i.e. Arc (Park et al., 2008).”
BackgroundInfluentialModeling Autism by SHANK Gene Mutations in Mice
Jiang, Y.-H., & Ehlers, M. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.016 · Cited by 488
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · cited 2×
“3.2. mGlu5 receptor-dependent activation of endocannabinoid signalling Endocannabinoids are ubiquitous modulators of cognitive functions and have received much attention as possible targets for diverse CNS diseases including psychiatric disorders (Campos et al., 2012).”
BackgroundInfluentialWaung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., & Huber, K. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.014 · Cited by 474 · cited 1×
“1, which regulates AMPA receptor endocytosis by interacting with endophylin2/3 and dynamin (Chowdhury et al., 2006; Park et al., 2008; Waung et al., 2008), and microtubule-associated protein 1b (Map1b), which interacts with GRIP1 (Davidkova and Carroll, 2007).”
BackgroundSelf-citationHou, L., Antion, M. D., Hu, D., Spencer, C. M., Paylor, R., & Klann, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.005 · Cited by 469 · cited 2×
“…in hippocampal CA1 slices from Fmr1 KO mice (Huber et al., 2002). mGlu-LTD in wild type rodents requires rapid dendritic protein synthesis (see above) and mGlu-LTD in Fmr1 KO slices, in addition to being enhanced, is independent of new protein synthesis (Hou et al., 2006; Nosyreva and Huber, 2006).”
BackgroundRapid Neocortical Dynamics: Cellular and Network Mechanisms
Haider, B., & McCormick, D. A. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.008 · Cited by 441
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438
The slow (<1 Hz) rhythm of non-REM sleep: a dialogue between three cardinal oscillators
Crunelli, V., & Hughes, S. W. (2010) · Nature Neuroscience · doi:10.1038/nn.2445 · Cited by 435 · cited 1×
“When UP states occur spontaneously and repeatedly, they underlie the neocortical “slow oscillation” (<1 Hz) during slow wave sleep and may be involved in long-term memory consolidation (Crunelli and Hughes, 2010; Ji and Wilson, 2007; Marshall and Born, 2007; Marshall et al., 2006).”
BackgroundOsterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · cited 1×
“Similar mechanisms may underlie audiogenic seizures in Fmr1 KO mice because inhibitors of the ERK pathway, applied acutely in vivo, also block seizures (Osterweil et al., 2013, 2010).”
BackgroundThe Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370 · cited 4×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript function are quite remarkable and illustrate that group-I mGlu receptor dysfunction is a large contributor to the pathophysiology of FXS (reviewed in Bhakar et al., 2012; Krueger and Bear, 2011).”
BackgroundInfluentialTakeuchi, M., Hata, Y., Hirao, K., Toyoda, A., Irie, M., & Takai, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11943 · Cited by 359
Gereau, R., & Conn, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06879.1995 · Cited by 352
Hung, A. Y., Futai, K., Sala, C., Valtschanoff, J. G., Ryu, J., Woodworth, M. A., Kidd, F. L., Sung, C. C., Miyakawa, T., Bear, M. F., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3032-07.2008 · Cited by 350 · cited 2×
“However, in Shank 1 and Shank 3 mutant mice a reduction of Homer1 proteins might implicate an alteration of mGlu5-mediated signalling in these mutant mice (Hung et al., 2008; Peça et al., 2011; Wang et al., 2011), whereas only NMDA receptor mediated signalling appear to be impaired in Shank 2 mutant mice (Won et al.”
BackgroundDoumazane, E., Scholler, P., Zwier, J. M., Trinquet, E., Rondard, P., & Pin, J. (2011) · The FASEB Journal · doi:10.1096/fj.10-163147 · Cited by 324 · cited 2×
“, mGlu1 with mGlu5 receptors), adding further complexity to the mode of action and mechanisms of regulation of group-I mGlu receptors (Doumazane et al., 2011).”
BackgroundSHANK1 Deletions in Males with Autism Spectrum Disorder
Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I. E., Hamdan, F. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.017 · Cited by 318 · cited 1×
“More recently, SHANK1 and SHANK2 have been also implicated in autism (Berkel et al., 2010; Sato et al., 2012).”
BackgroundShared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism
Baudouin, S. J., Gaudias, J., Gerharz, S., Hatstatt, L., Zhou, K., Punnakkal, P., Tanaka, K. F., Spooren, W., Hen, R., De Zeeuw, C. I., et al. (2012) · Science · doi:10.1126/science.1224159 · Cited by 293
Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome
Musumeci, S. A., Bosco, P., Calabrese, G., Bakker, C., De Sarro, G. B., Elia, M., Ferri, R., & Oostra, B. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01499.x · Cited by 289
Self-citationToward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript function are quite remarkable and illustrate that group-I mGlu receptor dysfunction is a large contributor to the pathophysiology of FXS (reviewed in Bhakar et al., 2012; Krueger and Bear, 2011).”
BackgroundDisrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., Hu, J.-H., Worley, P. F., Gibson, J. R., & Huber, K. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3033 · Cited by 251
Self-citationSilverman, J. L., Smith, D. G., Rizzo, S. J. S., Karras, M. N., Turner, S. M., Tolu, S. S., Bryce, D. K., Smith, D. L., Fonseca, K., Ring, R. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003501 · Cited by 251
Nakamoto, M., Nalavadi, V., Epstein, M. P., Narayanan, U., Bassell, G. J., & Warren, S. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707484104 · Cited by 245 · cited 2×
“The increased mGlu5 receptor activity is also responsible for an increased AMPA receptor endocytosis that is independent on endocannabinoids (Wan et al., 2011), pointing again to commonality with mGlu5-dependent AMPA receptor endocytosis observed in FXS (Nakamoto et al., 2007).”
BackgroundMetabotropic Glutamate Receptor-Mediated Long-Term Depression: Molecular Mechanisms
Gladding, C. M., Fitzjohn, S. M., & Molnár, E. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001735 · Cited by 233 · cited 2×
“While a detailed discussion of mGlu-LTD mechanisms is beyond the scope of this review, there have been several excellent reviews focused on mGluLTD (Asrar and Jia, 2013; Gladding et al., 2009; Lüscher and Huber, 2010).”
BackgroundOsterweil, E. K., Chuang, S.-C., Chubykin, A. A., Sidorov, M., Bianchi, R., Wong, R. K. S., & Bear, M. F. (2013) · Neuron · doi:10.1016/j.neuron.2012.01.034 · Cited by 230 · cited 1×
“Similar mechanisms may underlie audiogenic seizures in Fmr1 KO mice because inhibitors of the ERK pathway, applied acutely in vivo, also block seizures (Osterweil et al., 2013, 2010).”
BackgroundPhelan, M. C. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-14 · Cited by 221
Wiznitzer, M. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190090701 · Cited by 214
Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function
Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., & Sabatini, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1617-11.2011 · Cited by 204
Verpelli, C., Dvoretskova, E., Vicidomini, C., Rossi, F., Chiappalone, M., Schoen, M., Di Stefano, B., Mantegazza, R., Broccoli, V., Böckers, T. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258384 · Cited by 197
Betancur, C., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-17 · Cited by 189 · cited 1×
“Furthermore, mutations of SHANK3 are the most frequent among the rare variants found in autism (for review see Betancur and Buxbaum, 2013; Bourgeron, 2009) and have also been detected in non syndromic form of ID (Gong et al., 2012).”
BackgroundPTEN signaling in autism spectrum disorders
Zhou, J., & Parada, L. F. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.05.004 · Cited by 188
Moult, P. R., Gladding, C. M., Sanderson, T. M., Fitzjohn, S. M., Bashir, Z. I., Molnar, E., & Collingridge, G. L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4322-05.2006 · Cited by 172
Niere, F., Wilkerson, J. R., & Huber, K. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-11.2012 · Cited by 153 · cited 8×
“[PubMed: 23352161] Park S, Park JM, Kim S, Kim JA, Shepherd JD, Smith-Hicks CL, Chowdhury S, Kaufmann W, Kuhl D, Ryazanov AG, Huganir RL, Linden DJ, Worley PF. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.”
BackgroundSelf-citationDynamin 3 is a component of the postsynapse, where it interacts with mGluR5 and Homer
Gray, N. W., Fourgeaud, L., Huang, B., Chen, J., Cao, H., Oswald, B. J., Hémar, A., & McNiven, M. A. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00136-2 · Cited by 143 · cited 16×
“Interaction with Homer proteins controls several functions of mGlu1/5 receptors such as the constitutive activity of mGlu5 receptors (Ango et al., 2001), mGlu5 receptor trafficking and lateral mobility (Ango et al., 2001; Coutinho et al., 2001; Sergé et al., 2002), mGlu5 receptor coupling to ion channels (Kammermeier…”
BackgroundInfluentialvan Hooft, J. A., Giuffrida, R., Blatow, M., & Monyer, H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03544.2000 · Cited by 141 · cited 1×
“Both mGlu1 and mGlu5 receptors are present in cortical and hippocampal interneurons (van Hooft et al., 2000) where they interact with NMDA receptors in regulating neural oscillations and brain connectivity. mGlu5 receptors are also found in astrocytes, and their function is up-regulated during the…”
BackgroundGiuffrida, R., Musumeci, S., D'Antoni, S., Bonaccorso, C. M., Giuffrida-Stella, A. M., Oostra, B. A., & Catania, M. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0932-05.2005 · Cited by 141 · cited 4×
“, 2002) and forebrain synaptosomes (Giuffrida et al., 2005).”
BackgroundSelf-citationNalavadi, V. C., Muddashetty, R. S., Gross, C., & Bassell, G. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5057-11.2012 · Cited by 128
Kelleher III, R. J., Geigenmüller, U., Hovhannisyan, H., Trautman, E., Pinard, R., Rathmell, B., Carpenter, R., & Margulies, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035003 · Cited by 116
Sapap3 Deletion Causes mGluR5-Dependent Silencing of AMPAR Synapses
Wan, Y., Feng, G., & Calakos, N. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2533-11.2011 · Cited by 101
Chévere-Torres, I., Kaphzan, H., Bhattacharya, A., Kang, A., Maki, J. M., Gambello, M. J., Arbiser, J. L., Santini, E., & Klann, E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.028 · Cited by 83 · cited 4×
“These two proteins behave as GAPs (GTPase-activating proteins) of the small GTP-binding protein, Rheb (Ras homologue enriched in brain), thereby restraining the activation of mTORC1 (mammalian target of rapamycin complex 1) (Huang and Manning, 2008).”
BackgroundInfluentialSapap3 Deletion Anomalously Activates Short-Term Endocannabinoid-Mediated Synaptic Plasticity
Chen, M., Wan, Y., Ade, K., Ting, J., Feng, G., & Calakos, N. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1701-11.2011 · Cited by 82 · cited 1×
“In this mouse model, an excessive endocannabinoid mediated depression was detected at excitatory synapses of striatal medium spiny neurons which was caused by increased mGlu5 receptor expression/activity (Chen et al., 2011).”
BackgroundMusumeci, S. A., Calabrese, G., Bonaccorso, C. M., D'Antoni, S., Brouwer, J. R., Bakker, C. E., Elia, M., Ferri, R., Nelson, D. L., Oostra, B. A., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.007 · Cited by 70
Self-citation
Cited by
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara‐Solarz, S., de La Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13713 · Cited by 386
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00087 · Cited by 79
Oxytocin: Parallel Processing in the Social Brain?
Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65
López-Merino, E., Cuartero, M. I., Esteban, J. A., & Briz, V. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09697-2 · Cited by 44
“Particularly, synaptic plasticity events such as long-term potentiation (LTP) and long-term depression (LTD) are typically affected in genetic animal models of ASD and intellectual disability (D’Antoni et al. 2014; Knafo and Este-ban 2017).”
Background
Metadata
- Authors
- D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 46
- Pages
- 228-241
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2022138812
- Cited by
- 96
- References
- 71
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.